$23.21
▼ $0.29 (-1.2%)
ZYME
Zymeworks Inc. Common Stock
Health Care
Investor Score
47D+
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
36
Technical
30
Fundamental
82
Growth
38
Fair Value
62
News
58
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.